Abstract
BackgroundCardiovascular disease remains the leading cause of excessive morbidity and mortality in rheumatoid arthritis (RA). Atherosclerosis and RA share similar pathogenetic mechanisms1. Rosuvastatin and olmesartan improve inflammation and endothelial dysfunction...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
